Indeed, Met receptor phosphorylation induced by HGF is associated to the hyperexpression of mesenchymal markers and chemoresistance that result in a poor prognosis in SCLC patients [14, 15]. The gene discussed is HGF; the disease is small cell lung carcinoma.